Benchmark Reiterates Speculative Buy on Orgenesis, Maintains $6 Price Target
BenzingaJun 14, 2023 19:52
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Orgenesis (ORGS) and BELLUS Health (BLU)
TipRanksMar 23, 2023 00:37
No Data